Nassr Nassr

Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity

Róbert Hermann, Andreas Huennemeyer, B Hauns et al. · Clinical Pharmacology & Therapeutics · 2006 · 125 citations

Medicine, Genetics, Pharmacology +16

Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype

Zhengwen Jiang, Nadine Dragin, Lucia F. Jorge-Nebert et al. · Pharmacogenetics and Genomics · 2006 · 94 citations

Life Sciences, Genetics, Molecular Genetics +16

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N‐oxide in healthy subjects

Nassr Nassr, Andreas Huennemeyer, Rolf Herzog et al. · British Journal of Clinical Pharmacology · 2009 · 48 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Steady-State Pharmacokinetics of Roflumilast and Roflumilast N-Oxide in Patients with Mild and Moderate Liver Cirrhosis

Róbert Hermann, Nassr Nassr, Gëzim Lahu et al. · Clinical Pharmacokinetics · 2007 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +10

Lack of a pharmacokinetic interaction between steady‐state roflumilast and single‐dose midazolam in healthy subjects

Nassr Nassr, Gëzim Lahu, Oliver von Richter et al. · British Journal of Clinical Pharmacology · 2006 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16